Erratum: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Neuro-Oncology (2010) 12:2 (116-121))

A. L. Rivera, C. E. Pelloski, M. R. Gilbert, H. Colman, E. P. De La Sulman, C. Cruz, B. N. Bekele, K. D. Aldape

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Neuro-Oncology (2010) 12:2 (116-121))'. Together they form a unique fingerprint.